Ensign Peak Advisors »

Lyra Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.2M 302k 3.91
2023-06-30 $1.2M 302k 4.11
2023-03-31 $626k 302k 2.07
2022-12-31 $949k 302k 3.14
2022-09-30 $317k 63k 5.02
2022-06-30 $318k 56k 5.66
2022-03-31 $157k 39k 4.01
2021-12-31 $171k 39k 4.37
2021-09-30 $358k 39k 9.14
2021-06-30 $314k 39k 8.02
2021-03-31 $454k 39k 11.59
2020-12-31 $447k 39k 11.41
2020-09-30 $438k 39k 11.18
2020-06-30 $170k 15k 11.33